Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2015

01.01.2015 | Original Article

Transenteral Bowel Preparation for Colonoscopy Is More Comfortable than the Traditional Method with No Inferiority in Efficacy

verfasst von: Sung-Won Jung, Da Hye Jung, Young Chul Shin, In Ho Moh, Hana Yoo, Sung Il Jang, Su Rin Shin, Jin Bae Kim, Sang Hoon Park, Myung Seok Lee

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Transenteral (TE) administration of a bowel cleanser prior to colonoscopy avoids the discomfort associated with drinking a large volume of unpalatable cleanser.

Aim

To explore patient comfort, preference for future colonoscopy, the efficacy and adverse events associated with TE bowel preparation.

Methods

Bowel preparation is traditionally practised using polyethylene glycol (PEG) + ascorbic acid (ASC), which was the treatment used in the control group (peroral group; PO group). In the study group (TE group), PEG + ASC were administered directly to the third portion of the duodenum through a scope immediately after completing upper gastrointestinal endoscopy.

Results

A higher proportion of subjects in the TE group graded their degree of comfort as very or rather comfortable (28.4 % in the PO group, 65.1 % in the TE group; p = 0.000) and had greater preference for future colonoscopy (69.6 % in the PO group, 82.5 % in the TE group; p = 0.030), compared with the PO group. The TE group had non-inferiority in efficacy compared with the PO group (non-inferiority margin −15 %; lower limit of 95 % confidence interval for difference between success rates −6.4 %, when using the Aronchick Scale, and −7.1 % when using the Ottawa Scale). Nausea or vomiting were more prevalent during preparation in the PO group (46.1 vs. 17.5 %; p = 0.000), and dizziness was more common in the TE group (0 vs. 12.6 %; p = 0.000).

Conclusions

TE preparation was found to be more comfortable than the traditional peroral method and not inferior in efficacy. The adverse events rate was acceptable.
Literatur
1.
Zurück zum Zitat Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46:109–123.PubMedCentralPubMedCrossRef Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46:109–123.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Park B, Lee HY, Choi KS, Lee YY, Jun JK, Park EC. Cancer screening in Korea, 2010: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev. 2011;12:2123–2128.PubMed Park B, Lee HY, Choi KS, Lee YY, Jun JK, Park EC. Cancer screening in Korea, 2010: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev. 2011;12:2123–2128.PubMed
3.
Zurück zum Zitat Ell C, Fischbach W, Bronisch HJ, et al. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol. 2008;103:883–893.PubMedCrossRef Ell C, Fischbach W, Bronisch HJ, et al. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol. 2008;103:883–893.PubMedCrossRef
4.
Zurück zum Zitat Hookey LC, Vanner SJ. Pico-salax plus two-day bisacodyl is superior to pico-salax alone or oral sodium phosphate for colon cleansing before colonoscopy. Am J Gastroenterol. 2009;104:703–709.PubMedCrossRef Hookey LC, Vanner SJ. Pico-salax plus two-day bisacodyl is superior to pico-salax alone or oral sodium phosphate for colon cleansing before colonoscopy. Am J Gastroenterol. 2009;104:703–709.PubMedCrossRef
5.
Zurück zum Zitat Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc. 2007;65:648–656.PubMedCrossRef Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc. 2007;65:648–656.PubMedCrossRef
6.
Zurück zum Zitat Aronchick CA, Lipshutz WH, Wright SH, DuFrayne FJ, Bergman GE. Validation of an instrument to assess colon cleansing [abstract]. Am J Gastroenterol. 1999;94:2667. Aronchick CA, Lipshutz WH, Wright SH, DuFrayne FJ, Bergman GE. Validation of an instrument to assess colon cleansing [abstract]. Am J Gastroenterol. 1999;94:2667.
7.
Zurück zum Zitat Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc. 2004;59:482–486.PubMedCrossRef Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc. 2004;59:482–486.PubMedCrossRef
8.
Zurück zum Zitat Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc. 2005;61:378–384.PubMedCrossRef Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc. 2005;61:378–384.PubMedCrossRef
9.
Zurück zum Zitat Bernstein C, Thorn M, Monsees K, Spell R, O’Connor JB. A prospective study of factors that determine cecal intubation time at colonoscopy. Gastrointest Endosc. 2005;61:72–75.PubMedCrossRef Bernstein C, Thorn M, Monsees K, Spell R, O’Connor JB. A prospective study of factors that determine cecal intubation time at colonoscopy. Gastrointest Endosc. 2005;61:72–75.PubMedCrossRef
10.
Zurück zum Zitat Valiante F, Pontone S, Hassan C, et al. A randomized controlled trial evaluating a new 2-L PEG solution plus ascorbic acid vs 4-L PEG for bowel cleansing prior to colonoscopy. Dig Liver Dis. 2012;44:224–227.PubMedCrossRef Valiante F, Pontone S, Hassan C, et al. A randomized controlled trial evaluating a new 2-L PEG solution plus ascorbic acid vs 4-L PEG for bowel cleansing prior to colonoscopy. Dig Liver Dis. 2012;44:224–227.PubMedCrossRef
11.
Zurück zum Zitat Worthington J, Thyssen M, Chapman G, Chapman R, Geraint M. A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy. Curr Med Res Opin. 2008;24:481–488.PubMedCrossRef Worthington J, Thyssen M, Chapman G, Chapman R, Geraint M. A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy. Curr Med Res Opin. 2008;24:481–488.PubMedCrossRef
12.
Zurück zum Zitat Hoy SM, Scott LJ, Wagstaff AJ. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69:123–136.PubMedCrossRef Hoy SM, Scott LJ, Wagstaff AJ. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69:123–136.PubMedCrossRef
13.
Zurück zum Zitat Katz PO, Rex DK, Epstein M, et al. A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Am J Gastroenterol. 2013;108:401–409.PubMedCrossRef Katz PO, Rex DK, Epstein M, et al. A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Am J Gastroenterol. 2013;108:401–409.PubMedCrossRef
14.
Zurück zum Zitat Chorev N, Chadad B, Segal N, et al. Preparation for colonoscopy in hospitalized patients. Dig Dis Sci. 2007;52:835–839.PubMedCrossRef Chorev N, Chadad B, Segal N, et al. Preparation for colonoscopy in hospitalized patients. Dig Dis Sci. 2007;52:835–839.PubMedCrossRef
15.
Zurück zum Zitat Ness RM, Manam R, Hoen H, Chalasani N. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol. 2001;96:1797–1802.PubMedCrossRef Ness RM, Manam R, Hoen H, Chalasani N. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol. 2001;96:1797–1802.PubMedCrossRef
16.
Zurück zum Zitat Maeng JH, Ko BM, Lee MS, et al. Effectiveness and tolerance of duodenoscopic bowel preparation for colonoscopy. Korean J Gastroenterol. 2007;50:78–83.PubMed Maeng JH, Ko BM, Lee MS, et al. Effectiveness and tolerance of duodenoscopic bowel preparation for colonoscopy. Korean J Gastroenterol. 2007;50:78–83.PubMed
18.
Zurück zum Zitat Seo EH, Kim TO, Park MJ, et al. Optimal preparation-to-colonoscopy interval in split-dose PEG bowel preparation determines satisfactory bowel preparation quality: an observational prospective study. Gastrointest Endosc. 2012;75:583–590.PubMedCrossRef Seo EH, Kim TO, Park MJ, et al. Optimal preparation-to-colonoscopy interval in split-dose PEG bowel preparation determines satisfactory bowel preparation quality: an observational prospective study. Gastrointest Endosc. 2012;75:583–590.PubMedCrossRef
19.
Zurück zum Zitat Eun CS, Han DS, Hyun YS, et al. The timing of bowel preparation is more important than the timing of colonoscopy in determining the quality of bowel cleansing. Dig Dis Sci. 2011;56:539–544.PubMedCrossRef Eun CS, Han DS, Hyun YS, et al. The timing of bowel preparation is more important than the timing of colonoscopy in determining the quality of bowel cleansing. Dig Dis Sci. 2011;56:539–544.PubMedCrossRef
20.
Zurück zum Zitat Post RE, Dickerson LM. Dizziness: a diagnostic approach. Am Fam Physician. 2010;82:361–368.PubMed Post RE, Dickerson LM. Dizziness: a diagnostic approach. Am Fam Physician. 2010;82:361–368.PubMed
Metadaten
Titel
Transenteral Bowel Preparation for Colonoscopy Is More Comfortable than the Traditional Method with No Inferiority in Efficacy
verfasst von
Sung-Won Jung
Da Hye Jung
Young Chul Shin
In Ho Moh
Hana Yoo
Sung Il Jang
Su Rin Shin
Jin Bae Kim
Sang Hoon Park
Myung Seok Lee
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2015
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3344-7

Weitere Artikel der Ausgabe 1/2015

Digestive Diseases and Sciences 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.